FindTrial
Sign In

The Pneumocystoscopic Transurethral Tumorresection using Photodynamic Diagnosis

The Pneumocystoscopic Transurethral Tumorresection using Photodynamic Diagnosis - Pneu-TUR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030549
Enrollment
215
Registered
2023-05-11
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C67.9 C53.9 C18.9 C20

Interventions

Group 1: Control with the use of water during the transurethral procedure Group 2: Use of air instead of water during the transurethral procedure

Sponsors

Charité – Universitätsmedizin Berlin Klinik für Urologie Campus Benjamin Franklin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Planned transurethral tumor resection

Exclusion criteria

Exclusion criteria: Allergy to hexaminolevulinate (Hevix) or indocyanine green (ICG); Planned open or laparoscopic tumor resection.

Design outcomes

Primary

MeasureTime frame
Recurrence rate in the first year—

Secondary

MeasureTime frame
Complication rate; surgery time—

Countries

Germany

Contacts

Public ContactNicolas Hertzsprung

Charité – Universitätsmedizin BerlinKlinik für Urologie Campus Benjamin Franklin

nicolas.hertzsprung@charite.de+49 30 450 615 348

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026